Phase II--clinical trial with biodegradable subdermal contraceptive implant Capronor (4.0-cm single implant) . Indian Council of Medical Research Task Force on Hormonal Contraception
Contraception 44(4): 409-417
1991
ISSN/ISBN: 0010-7824 PMID: 1756628 Document Number: 315511
The subdermal biodegradable contraceptive implant Capronor (4.0 cm) was implanted in 41 women to observe the efficacy and side effects. Only one pregnancy was reported at 10 months of use, and the life table continuation rate at 12 months was 82.2 per 100 users. No serious clinical side effects were reported during the study period. The menstrual pattern was disrupted during the first 3 months of implant use in two-thirds of the women which improved by the end of 12 months of use. The results of this Phase II study suggest that Capronor is a safe and effective long-acting contraceptive. These findings need to be confirmed in a Phase III clinical trial on a larger sample size.
Document emailed within 1 workday
Related Documents
Indian-Counc-Med-Res-Task-Force-Horm-Contracept 1991: Phase ii clinical trial with biodegradable subdermal contraceptive implant capronor 4.0 cm single implant Contraception 44(4): 409-418Baweja, R.; Bhattacharya, S.K.; Choudhury, S.D.; Krishna, U.; Manuel, M.; Phillips, F.S.; Datey, S.; Kumar, S.; Mehta, S.; Saxena, N.C. 1985: Indian Council of Medical Research. Task Force on Hormonal Contraception: Phase II randomized clinical trial with norethisterone oenanthate 50 mg alone and in combination with 5 mg or 2.5 mg of either estradiol valerate or cypionate as a monthly injectable contraceptive Contraception 32(4): 383-394
I, 1991: Phase II : clinical trial with biodegradable subdermal contraceptive implant capronorR (4.0-cm single implant) Contraception (Stoneham) 44(4): 409-417
Buckshee, K.; Chatterjee, P.; Dhall, G.I.; Hazra, M.N.; Kodkany, B.S.; Lalitha, K.; Logambal, A.; Manchanda, P.; Nanda, U.K.; RaiChoudhury, G. 1995: Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception Contraception 51(4): 237-242
Buckshee, K.; Chatterjee, P.; Dhall, G.I.; Hazra, M.N.; Kodkany, B.S.; Lalitha, K.; Logambal, A.; Manchanda, P.; Nanda, U.K.; RaiChoudhury, G. 1995: Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception Contraception 51(4): 237-242
Bhatia, P.; Nangia, S.; Aggarwal, S.; Tewari, C. 2011: Implanon: subdermal single rod contraceptive implant Journal of Obstetrics and Gynaecology of India 61(4): 422-425
Anon 1983: Immediate sequelae following tubal sterilization indian council of medical research task force on female sterilization Contraception 28(4): 369-384
Anon 1983: Immediate sequelae following tubal sterilization indian council of medical research task force on female sterilization Contraception 28(4): 369-384
Anon 1983: Immediate sequelae following tubal sterilization indian council of medical research task force on female sterilization Contraception 28(4): 369-384
Chaudhury, N.; Gupta, A.N.; Hazra, M.N.; Hingorani, V.; Kochhar, M.; Kodkany, B.S.; Logambal, A.; Nanda, U.K.; Raja Ram, P.; Rai Choudhary, G. 1988: Phase III-clinical trial with Norplant-2 (covered rods). Report of a 24-month study. National Programme of Research in Human Reproduction. Division of Human Resource Development Research Indian Council of Medical Research Ansari Nagar, New Delhi, India Contraception 38(6): 659-673
Betrabet, S.S.; Shikary, Z.K.; Toddywalla, V.S.; Toddywalla, S.P.; Patel, D.; Saxena, B.N. 1987: ICMR Task Force Study on hormonal contraception. Transfer of norethisterone (NET) and levonorgestrel (LNG) from a single tablet into the infant's circulation through the mother's milk Contraception 35(6): 517-522
Koetsawang, S.; Ji, G.; Krishna, U.; Cuadros, A.; Dhall, G.I.; Wyss, R.; Rodriquez la Puenta, J.; Andrade, A.T.; Khan, T.; Kononova, E.S. 1990: Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Contraception 41(2): 105-124
Hingorani, V.; Jalnawala, S.F.; Kochhar, M.; Rai Chaudhury, G.; Sengupta, P.C.; Datey, S.; Mehta, S.; Roy, M.; Saxena, N.C.; Saxena, B.N. 1986: Phase II randomized comparative clinical trial of Norplant (six capsules) with Norplant-2 (two covered rods) subdermal implants for long-term contraception: report of a 24-month study. National Programme of Research in Human Reproduction Contraception 33(3): 233-244
Hingorani, V.; Jalnawala, S.F.; Kochhar, M.; Rai Chaudhury, G.; Sengupta, P.C.; Datey, S.; Mehta, S.; Roy, M.; Saxena, N.C.; Saxena, B.N. 1986: Phase II randomized comparative clinical trial of Norplant (six capsules) with Norplant-2 (two covered rods) subdermal implants for long-term contraception: report of a 24-month study. National Programme of Research in Human Reproduction Contraception 33(3): 233-244
Barros Pereira, I.; Carvalho, R.M.; Graça, L.ís.M. 2015: Intra-abortion contraception with etonogestrel subdermal implant European Journal of Obstetrics Gynecology and Reproductive Biology 185: 33-35
Das, C; Talwar, G P. 1983: Pregnancy-terminating action of a luteinizing hormone-releasing hormone agonist d-Ser(But)6desGly10ProEA in baboons**This work was conducted cooperatively with the International Committee for Contraception Research of the Population Council, New York, and was supported by research grants from the Rockefeller Foundation, the International Development Research Centre of Canada, the Family Planning Foundation of India, and the Indian Council of Medical Research Fertility and Sterility 39(2): 218-223
Das, C; Talwar, G P. 1983: Pregnancy-terminating action of a luteinizing hormone-releasing hormone agonist d-Ser(But)6desGly10ProEA in baboons**This work was conducted cooperatively with the International Committee for Contraception Research of the Population Council, New York, and was supported by research grants from the Rockefeller Foundation, the International Development Research Centre of Canada, the Family Planning Foundation of India, and the Indian Council of Medical Research Fertility and Sterility 39(2): 218-223
Das, C; Talwar, G P. 1983: Pregnancy-terminating action of a luteinizing hormone-releasing hormone agonist d-Ser(But)6desGly10ProEA in baboons**This work was conducted cooperatively with the International Committee for Contraception Research of the Population Council, New York, and was supported by research grants from the Rockefeller Foundation, the International Development Research Centre of Canada, the Family Planning Foundation of India, and the Indian Council of Medical Research Fertility and Sterility 39(2): 218-223
Das, C; Talwar, G P. 1983: Pregnancy-terminating action of a luteinizing hormone-releasing hormone agonist d-Ser(But)6desGly10ProEA in baboons**This work was conducted cooperatively with the International Committee for Contraception Research of the Population Council, New York, and was supported by research grants from the Rockefeller Foundation, the International Development Research Centre of Canada, the Family Planning Foundation of India, and the Indian Council of Medical Research Fertility and Sterility 39(2): 218-223
Hernandez-Juarez, J.; Sanchez-Serrano, J.C.; Moreno-Hernandez, M.; Alvarado-Moreno, J.A.; Hernandez-Lopez, J.R.; Isordia-Salas, I.; Majluf-Cruz, A. 2015: Effects of the contraceptive skin patch and subdermal contraceptive implant on markers of endothelial cell activation and inflammation Journal of Clinical Pharmacology 55(7): 780-786